TW200637804A - Substantially pure tolterodine tartrate and process for preparing thereof - Google Patents
Substantially pure tolterodine tartrate and process for preparing thereofInfo
- Publication number
- TW200637804A TW200637804A TW095100930A TW95100930A TW200637804A TW 200637804 A TW200637804 A TW 200637804A TW 095100930 A TW095100930 A TW 095100930A TW 95100930 A TW95100930 A TW 95100930A TW 200637804 A TW200637804 A TW 200637804A
- Authority
- TW
- Taiwan
- Prior art keywords
- substantially pure
- preparing
- tolterodine tartrate
- pure tolterodine
- tartrate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
- C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/10—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64286605P | 2005-01-10 | 2005-01-10 | |
US69082305P | 2005-06-14 | 2005-06-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200637804A true TW200637804A (en) | 2006-11-01 |
Family
ID=36216777
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW095100930A TW200637804A (en) | 2005-01-10 | 2006-01-10 | Substantially pure tolterodine tartrate and process for preparing thereof |
TW095100936A TW200640839A (en) | 2005-01-10 | 2006-01-10 | Process for preparing Tolterodine tartrate |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW095100936A TW200640839A (en) | 2005-01-10 | 2006-01-10 | Process for preparing Tolterodine tartrate |
Country Status (7)
Country | Link |
---|---|
US (2) | US20060194876A1 (zh) |
EP (2) | EP1843999A1 (zh) |
JP (2) | JP2007527923A (zh) |
CA (2) | CA2590555A1 (zh) |
IL (2) | IL183243A0 (zh) |
TW (2) | TW200637804A (zh) |
WO (2) | WO2006074479A1 (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR057333A1 (es) * | 2005-05-27 | 2007-11-28 | Medichem Sa | Proceso para la preparacion de 3,3-diarilpropilaminas |
CZ302585B6 (cs) * | 2007-02-26 | 2011-07-20 | Zentiva, A. S. | Krystalická sul 2-[(1R)-3-[bis(1-methylethyl)amino]-1-fenylpropyl]-4-methylfenolu s kyselinou (2R,3R)-2,3-dihydroxybutandiovou |
WO2009019599A2 (en) | 2007-08-08 | 2009-02-12 | Themis Laboratories Private Limited | Extended release compositions comprising tolterodine |
US20090214665A1 (en) * | 2008-02-26 | 2009-08-27 | Lai Felix S | Controlled Release Muscarinic Receptor Antagonist Formulation |
WO2010046801A2 (en) * | 2008-10-21 | 2010-04-29 | Alembic Limited | A process for the preparation of tolterodine tartrate |
EP2398765A1 (en) * | 2009-02-17 | 2011-12-28 | Pharmathen S.A. | Improved process for the preparation of (r)-2-(3-diisopropylamino)-1-phenylpropyl)-4methylphenol and salts thereof |
CN102368061A (zh) * | 2011-03-22 | 2012-03-07 | 鲁南制药集团股份有限公司 | 一种酒石酸托特罗定原料或制剂的有关物质检测方法 |
CN103044274B (zh) * | 2012-11-29 | 2014-10-22 | 珠海保税区丽珠合成制药有限公司 | 一种无溶剂合成酒石酸托特罗定的方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5382600A (en) * | 1988-01-22 | 1995-01-17 | Pharmacia Aktiebolag | 3,3-diphenylpropylamines and pharmaceutical compositions thereof |
US5283058A (en) * | 1990-08-30 | 1994-02-01 | The General Hospital Corporation | Methods for inhibiting rejection of transplanted tissue |
SE9203318D0 (sv) * | 1992-11-06 | 1992-11-06 | Kabi Pharmacia Ab | Novel 3,3-diphenylpropylamines, their use and preparation |
KR20000057548A (ko) * | 1996-12-13 | 2000-09-25 | 알프레드 엘. 미첼슨 | 광학적 전송물질 및 결합재 |
SE9803871D0 (sv) * | 1998-11-11 | 1998-11-11 | Pharmacia & Upjohn Ab | Therapeutic method and formulation |
DE19922662C1 (de) * | 1999-05-18 | 2000-12-28 | Sanol Arznei Schwarz Gmbh | Transdermales therapeutisches System (TTS) Tolterodin enthaltend |
DE10028443C1 (de) * | 2000-06-14 | 2002-05-29 | Sanol Arznei Schwarz Gmbh | Verfahren zur Herstellung von 3,3-Diarylpropylaminen, (R,S)- und (R)-4-Phenyl-2-chromanon-6-carbonsäure sowie (R)-4-Phenyl-2-chromanon-carbonsäure-cinchonidinsalz und deren Verwendung zur Herstellung eines rechtsdrehenden Hydroxybenzylalkohols und von pharmazeutischen Zusammensetzungen |
IN191835B (zh) * | 2001-08-03 | 2004-01-10 | Ranbaxy Lab Ltd | |
WO2003053428A1 (en) * | 2001-12-20 | 2003-07-03 | Pharmacia Corporation | Controlled release dosage form having improved drug release properties |
CA2517824A1 (en) * | 2003-03-06 | 2004-09-16 | Neela Praveen Kumar | 3,3-diarylpropylamine derivatives and processes for isolation thereof |
-
2006
- 2006-01-10 EP EP06718038A patent/EP1843999A1/en not_active Withdrawn
- 2006-01-10 WO PCT/US2006/000917 patent/WO2006074479A1/en active Application Filing
- 2006-01-10 US US11/329,915 patent/US20060194876A1/en not_active Abandoned
- 2006-01-10 CA CA002590555A patent/CA2590555A1/en not_active Abandoned
- 2006-01-10 TW TW095100930A patent/TW200637804A/zh unknown
- 2006-01-10 EP EP06718037A patent/EP1836156A1/en not_active Withdrawn
- 2006-01-10 CA CA002590556A patent/CA2590556A1/en not_active Abandoned
- 2006-01-10 WO PCT/US2006/000916 patent/WO2006074478A1/en active Application Filing
- 2006-01-10 TW TW095100936A patent/TW200640839A/zh unknown
- 2006-01-10 JP JP2007503129A patent/JP2007527923A/ja active Pending
- 2006-01-10 JP JP2007503128A patent/JP2007527922A/ja active Pending
- 2006-01-10 US US11/329,922 patent/US20060194987A1/en not_active Abandoned
-
2007
- 2007-05-15 IL IL183243A patent/IL183243A0/en unknown
- 2007-05-15 IL IL183242A patent/IL183242A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL183242A0 (en) | 2007-08-19 |
US20060194876A1 (en) | 2006-08-31 |
US20060194987A1 (en) | 2006-08-31 |
JP2007527923A (ja) | 2007-10-04 |
WO2006074478A1 (en) | 2006-07-13 |
IL183243A0 (en) | 2007-08-19 |
EP1836156A1 (en) | 2007-09-26 |
CA2590556A1 (en) | 2006-07-13 |
CA2590555A1 (en) | 2006-07-13 |
EP1843999A1 (en) | 2007-10-17 |
JP2007527922A (ja) | 2007-10-04 |
TW200640839A (en) | 2006-12-01 |
WO2006074479A1 (en) | 2006-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL185107A0 (en) | Process for preparing cinacalcet hydrochloride | |
IL176142A0 (en) | Processes for preparing montelukast sodium | |
TW200716512A (en) | Processes for preparing cinacalcet hydrochloride crystal form I | |
UA97382C2 (ru) | Таннат разагилина | |
TW200617019A (en) | A process for the preparation of 7α-alkylated 19-norsteroids | |
MX2008001652A (es) | Copolimeros de poliamonio-polisiloxano. | |
TW200637804A (en) | Substantially pure tolterodine tartrate and process for preparing thereof | |
TW200717389A (en) | Luminance adjustment | |
SG166091A1 (en) | Method for producing isocyanates | |
EP1867698A4 (en) | FLUORESCENT AND MANUFACTURING METHOD THEREFOR | |
IL185031A0 (en) | Method for the preparation of pregabalin and salts thereof | |
IL188431A0 (en) | Process for preparing 3-arylmethylthio-and 3-heteroarylmethylthio-4,5-dihydro- | |
TW200744567A (en) | Phenylethylamine analogs and their use for treating glaucoma | |
TW200833649A (en) | Method for the preparation of hydroxyadamantanamine | |
TW200730521A (en) | Triazine compounds having amino-and carboxyl-containing substituents | |
TW200637832A (en) | Process for preparing amorphous valsartan | |
TW200630348A (en) | Tadalafil crystal forms and processes for preparing them | |
WO2008015584A3 (en) | Improved process for synthesizing desvenlafaxine free base and salts or solvates thereof | |
EG25292A (en) | Process for the production of anilines. | |
IL187673A0 (en) | Process for preparing 3,3-diarylpropylamines | |
IL176512A0 (en) | Process for preparing high-purity, halogen-free o-phthalaldehyde | |
MX2009006748A (es) | Proceso para la preparacion y aislamiento de los estereoisomeros individuales de fenilciclopentan-carboxilatos 3-sustituidos de 1-amino. | |
TW200640836A (en) | Processes for preparing sertraline | |
IL187658A0 (en) | Process for the preparation of 3,7-dihydroxy-1,5-diazacyclooctanes | |
IL184836A0 (en) | Processes for preparing sertraline |